If you're having trouble viewing this email, you can read it online.

 
Thursday, May 22, 2008
 
 
•  IVIG Supply Index •  Open Market Pricing  
•  Albumin Supply Index •  Subscribe to IG Living  
•  In the News •  MyFluVaccine Orders  
•  FFF News •  Current Reimbursement Rates  
 
 


IVIG Supply Index represents FFF's aggregate inventory of all IVIG products for all our customers who have established product allocations with us (not individual or group allocations). Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.

 


Albumin Supply Index represents FFF's aggregate inventory of Albumin for all our customers who have established product allocations with us (not individual or group allocations). Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.
 

From CDC
CDC Recommends Shingles Vaccine

From Press Release
APIC Recommendations on Infection Prevention in Long-Term Care Facilities

From CIDRAP
Provider Issue Vexes Drive to Boost Flu Shot Coverage

From U.S. Department of Health & Human Services
Federal Guidance to Assist States in Improving State-Level Pandemic Influenza Operating Plans

From FDA
FDA Approves New Formulation of Coagulation Therapy

From Grifols
Grifols Obtains FDA License for New Filling Area at Its Plasma Products Plant in the USA

From CNN
Seven Vaccines You Need Right Now

From Reuters
U.S. Doctors Miss Chances to Give Flu Vaccines

 

Flu Vaccine Myth Must Be Dispelled

Experts concur that lower effectiveness of flu vaccine one year doesn’t reduce the importance of vaccination in following years.

But, according to Luke Noll, Director of Corporate Accounts for Vaccines and Influenza Treatment at FFF Enterprises, those who are unaware of this might question whether a vaccine is worthwhile.

“That will be the primary myth and belief that must be overcome next season,” Noll said after attending the 2008 National Flu Vaccine Summit in May, which was sponsored by the American Medical Association (AMA), the Centers for Disease Control (CDC), and the Department of Health and Human Services (HHS). At the summit, a session was devoted to the topic of myths and the flu vaccine.

According to Dr. Frank S. Virant, who practices at the Northwest Asthma and Allergy Center in Seattle, Wash., chances are slim that last year—which had an overall vaccine effectiveness rate of 44 percent—will repeat itself.

“Some people might be frustrated that they ‘got the flu anyway,’ " Dr. Virant said, “but they should realize this phenomenon only happens every 15 to 20 years ... this is very unlikely to occur again for several years.”

Also, last year’s vaccine still provided cross-protection benefits against viruses related to the circulating A strain.

So “when you talk about the overall effectiveness of the flu vaccine for the past 16 out of 20 years, it was a good match,” Noll stated, referring to the vaccine’s 58 percent effectiveness against circulating influenza A viruses.

You can read more about this topic in an upcoming issue of IG Living magazine. Subscribe here.

      
 
 
  Albumin All Sizes Varies  
 
 
 
 
  Carimune NF All Sizes $59.30/gm  
  Flebogamma All Sizes $76.40/gm  
  Gammagard Liquid All Sizes $76.40/gm  
  Gammagard S/D All Sizes $75.50/gm  
  Gamunex All Sizes $76.40/gm  
  Octagam All Sizes $76.40/gm  
 
 
 
 
  All Hyperimmunes All Sizes Varies  
 
 
 
 
- Hyperimmune
- Immune Globulin
- Factor
- Injectable Influenza
 
 
Reimbursement Rates
Flebogamma injection:
  $65.062/gm
Gammagard liquid injection:
  $63.574/gm
Gamunex injection:
  $66.896/gm
Immune globulin powder:
  $56.13/gm
Octagam injection:
  $68.138/gm
Privigen injection:
  $68.37/gm
  Effective through
June 30, 2008
 
 
Manufacturer/Product
Apotex
  - HepaGam B
Baxter
  - WinRho SDF liquid
CSL Behring
 

- CytoGam
- Rhophylac

Genzyme
  - Thymoglobulin
Massachusetts
Public Health Biologic
Laboratories
  - BabyBIG
sanofi pasteur
  - Imogam Rabies-HT
Talecris
  - HyperHEP B S/D
- HyperRAB S/D
- HyperRHO S/D
- HyperTET S/D
 
 
 
 
 

BioSupply Trends is published by FFF Enterprises, the nation's most trusted distributor of biopharmaceuticals, plasma products and vaccines. FFF Enterprises is accelerating the availability of products, from development to delivery. CIick here to contact FFF Enterprises or call 800-843-7477.

This email was sent to: %%emailaddr%%
Unsubscribe
Update Profile
I want to report technical trouble with BioSupply Trends

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%